Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Aquestive Therapeutics Inc (AQST)

Aquestive Therapeutics Inc (AQST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Aquestive Therapeutics Inc 30 TECHNOLOGY DRIVE WARREN NJ 07059 USA

www.aquestive.com P: 908-941-1900

Description:

Aquestive Therapeutics, Inc. is a specialty pharmaceutical company. It commercializes medicines to solve critical health care problems as well as engages on late-stage proprietary product pipeline which focuses on the treatment of diseases of central nervous system. Aquestive Therapeutics, Inc. is based in NJ, United States.

Key Statistics

Overview:

Market Capitalization, $K 282,209
Enterprise Value, $K 285,849
Shares Outstanding, K 73,301
Annual Sales, $ 50,580 K
Annual Net Income, $ -7,870 K
Last Quarter Sales, $ 13,210 K
Last Quarter Net Income, $ -8,110 K
EBIT, $ -15,110 K
EBITDA, $ -11,790 K
60-Month Beta 2.87
% of Insider Shareholders 8.39%
% of Institutional Shareholders 32.45%
Float, K 67,151
% Float 91.61%
Short Volume Ratio 0.62

Growth:

1-Year Return 185.09%
3-Year Return -4.62%
5-Year Return -28.73%
5-Year Revenue Growth -24.99%
5-Year Earnings Growth 95.36%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.12 on 03/05/24
Latest Earnings Date 05/07/24
Earnings Per Share ttm -0.14
EPS Growth vs. Prev Qtr -300.00%
EPS Growth vs. Prev Year 47.83%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

AQST Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % -13.39%
Profit Margin % -15.56%
Debt/Equity -0.26
Price/Sales 5.71
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -1.59
Interest Coverage -0.02
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar